97 filings
Page 4 of 5
6-K
mok7l5i
27 Sep 22
Current report (foreign)
6:03am
6-K
wlhmgklavfgipv3
20 Sep 22
Current report (foreign)
4:30pm
6-K
lm9pfm3h05h8pb5p0yv
13 Sep 22
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Appeal
4:30pm
6-K
nlf0 ytt7mvh1g8r6pm
5 Aug 22
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
4:35pm
6-K
gr03n 4wj
18 Jul 22
Current report (foreign)
5:00pm
6-K
nzal fxgj02anbz
21 Jun 22
Current report (foreign)
6:05am
6-K
xe6i4
31 May 22
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
5:10pm
6-K
w47h dq6q0
26 May 22
Current report (foreign)
3:00pm
6-K
6cyfbxmy8fx25g6xbc
11 May 22
AnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital Market
8:04am
6-K
78itshmxhir 55shj
9 May 22
Current report (foreign)
7:31am
6-K
g4mbndpoxi yd9
6 May 22
Nasdaq Hearing Panel Grants AnPac Bio’s Request to Transfer Securities from The Nasdaq Global Market to The Nasdaq Capital Market
8:00am
6-K
fe0qu6n
21 Apr 22
Current report (foreign)
4:07pm
6-K
ysxxmg be
11 Apr 22
AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board
5:15pm
6-K
7ml1f4 k8q
28 Mar 22
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
5:00pm
6-K
ijas6
11 Mar 22
AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
4:40pm
6-K
7h6fk5r3l5nvdib 25q
15 Feb 22
Current report (foreign)
4:30pm
6-K
rtw3tqb10j554pprkajz
24 Jan 22
AnPac Bio Receives NASDAQ Notification Regarding
5:00pm
6-K
6f5z4c6e2uk0
26 Nov 21
Current report (foreign)
1:30pm
6-K
o3b33e2goes3ae3ih4r
15 Nov 21
Current report (foreign)
12:00am
6-K
2h9p83t8mzx4
12 Nov 21
AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares
7:00am